Učitavanje...
A-1210477, a selective MCL-1 inhibitor, overcomes ABT-737 resistance in AML
Acute myeloid leukemia (AML) is one of the most common hematological malignancies. It is difficult to treat since it easily develops resistance to therapeutic drugs. Myeloid cell leukemia 1 (MCL-1), BCL-2 and BCL-XL, which belong to the anti-apoptotic group of proteins in the BCL-2 family, are overe...
Spremljeno u:
| Izdano u: | Oncol Lett |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6781566/ https://ncbi.nlm.nih.gov/pubmed/31612056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10891 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|